Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue
about
Angiopoietin-like 4 regulates epidermal differentiation.Atypical angiopoietin-like protein that regulates ANGPTL3GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophagesAngiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migrationMolecular processes that handle -- and mishandle -- dietary lipidsTriglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?The Intestinal Microbiota in Metabolic DiseaseThe ANGPTL3-4-8 model, a molecular mechanism for triglyceride traffickingProbiotics and Prebiotics: Present Status and Future Perspectives on Metabolic DisordersGlycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteinsThe angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanismsFatty acid-inducible ANGPTL4 governs lipid metabolic response to exerciseAngiopoietin-like protein 4: health effects, modulating agents and structure-function relationshipsAngiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formationANGPTL4 is produced by entero-endocrine cells in the human intestinal tractCold acclimation induces physiological cardiac hypertrophy and increases assimilation of triacylglycerol metabolism through lipoprotein lipaseIn vivo imaging and genetic analysis link bacterial motility and symbiosis in the zebrafish gut.Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γAnalysis of knockout mice suggests a role for VGF in the control of fat storage and energy expenditureAngiopoietin-like 7 secretion is induced by glaucoma stimuli and its concentration is elevated in glaucomatous aqueous humor.Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemiaDecreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4)GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons.ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical TrialCirculating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome.Genetic causes of high and low serum HDL-cholesterol.GPIHBP1 and the processing of triglyceride-rich lipoproteinsLinking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue.A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase.Inflammation increases plasma angiopoietin-like protein 4 in patients with the metabolic syndrome and type 2 diabetes.Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity.Lipoprotein lipase: from gene to obesity.Lack of relationship between cord serum angiopoietin-like protein 4 (ANGPTL4) and lipolytic activity in human neonates born by spontaneous delivery.Severity of diabetes governs vascular lipoprotein lipase by affecting enzyme dimerization and disassemblyPostnatal lymphatic partitioning from the blood vasculature in the small intestine requires fasting-induced adipose factor.Determination of lipoprotein lipase activity using a novel fluorescent lipase assay.Lipase maturation factor 1: a lipase chaperone involved in lipid metabolism.Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea.The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk.
P2860
Q21135146-1021E4C6-1FB8-492C-8FF9-CBCB4FAE47D9Q24303810-8F14806D-5230-493C-A298-010C2AC288D7Q24338849-C5CC42EE-0F84-439C-8120-449FB0046512Q24594623-F980148C-FAAD-4013-9625-311A1517422AQ24633821-C9D8B9AE-9E55-41BC-B8DD-A51B88402155Q24642118-0B75A2CC-6F81-49F2-BCF5-534070A86614Q26746279-92D35C31-405E-4D90-B407-228727A6C884Q26750612-4AC4A928-65BF-46E6-B48B-0413045A3E8AQ26751057-BAFB340C-0C14-4C79-9765-370856E040DCQ26752979-0A312BC6-3569-40D5-ABC2-142487F5E5A9Q26851942-6B362B5C-F051-4F5F-995C-FAF65D6F8CDDQ28118447-FAE84150-6510-4F9E-98C3-74852EABDBDAQ28235151-48A0B6CD-3868-495E-BF20-C3F7893CEE04Q28263229-C9CC048B-48DF-4812-8669-AAB31677C814Q28296885-F7B0F01C-6588-4695-B91C-28D1007D7DB7Q28300566-154E9452-BDA3-4D8B-A116-D96F5CBF21E0Q28566312-453F0BEF-1E9E-40EA-8BBA-242D64919D35Q30479332-E644E91F-2F6F-483B-ABC4-C063D09F1E1DQ30538765-5E56DB06-BE19-4A98-BDAF-FAD27BAFD997Q33513320-48F9456E-1448-43C0-80F6-FC15921F58F1Q33621903-FE6348DE-C2D4-455C-B122-053B930889F6Q33644452-B8D4699E-8BE4-4050-80C8-0532B3E4E410Q33711961-33ECA0E8-6791-4A64-8DF1-84E9DC16BDCEQ33923844-689D61BC-A502-4158-B65F-B16D8397DF3FQ33946007-00280510-8962-4174-AA2F-339B777BAFE4Q33968126-81E62C19-ED03-49F2-8E6D-7CED7EA902F1Q33993060-F4083A52-5F66-40E7-972C-49461DE134A2Q34193260-47CEDEFC-0922-4894-9008-9255B2097FB4Q34486733-F3B4A181-EDAD-45D3-812B-DE51D8BAD190Q34505898-7FA8B5CC-D218-49F8-A160-4270B53AB5AAQ34692490-02A98667-8567-4093-AA47-28E7EA396586Q34963041-5B04680E-9D66-46F7-8093-003935D6E88CQ34968373-A390D156-F64A-458B-90E9-7E4E04B8219BQ35063919-6117FE41-0068-4192-9D28-9E8636E97E2FQ35123557-C2F18DF8-E1AD-4837-980B-F8089767DC96Q35568473-EB17F17B-4A50-4A72-86A5-35C8D8F8BC69Q35771182-75537680-8E00-4D97-A8CA-E17D5037C694Q35784094-93B3EF90-FDDA-4D19-A50B-2E5F7F71216AQ35830163-4077417E-B1B0-4AD0-A324-4AAB2C7E0373Q35869973-ED41E2A2-41D0-4354-8FD1-74E197C85D2F
P2860
Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Angiopoietin-like protein 4 co ...... ase activity in adipose tissue
@ast
Angiopoietin-like protein 4 co ...... ase activity in adipose tissue
@en
Angiopoietin-like protein 4 co ...... ase activity in adipose tissue
@nl
type
label
Angiopoietin-like protein 4 co ...... ase activity in adipose tissue
@ast
Angiopoietin-like protein 4 co ...... ase activity in adipose tissue
@en
Angiopoietin-like protein 4 co ...... ase activity in adipose tissue
@nl
prefLabel
Angiopoietin-like protein 4 co ...... ase activity in adipose tissue
@ast
Angiopoietin-like protein 4 co ...... ase activity in adipose tissue
@en
Angiopoietin-like protein 4 co ...... ase activity in adipose tissue
@nl
P2093
P2860
P3181
P356
P1476
Angiopoietin-like protein 4 co ...... ase activity in adipose tissue
@en
P2093
Aivar Lookene
Thomas Olivecrona
Valentina Sukonina
P2860
P304
P3181
P356
10.1073/PNAS.0604026103
P407
P577
2006-11-14T00:00:00Z